{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE230nnn/GSE230328/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230328"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer","description":"This SuperSeries is composed of the SubSeries listed below.","dates":{"publication":"2026/03/19"},"accession":"GSE230328","cross_references":{"GSM":["GSM7213901","GSM7213912","GSM7213913","GSM7213902","GSM7213914","GSM7213903","GSM7213904","GSM7213915","GSM7213910","GSM7213900","GSM7213911","GSM7213909","GSM7213905","GSM7213906","GSM7213907","GSM7213908"],"GPL":["20301","24676"],"GSE":["230328"],"taxon":["Homo sapiens"]}}